Introduction: Carcinoma of breast is the most frequently diagnosed cancer in the most of the countries and is also the leading cause of cancer death. Breast cancer is the most common cancer in India with ASR incidence 24.7/100,000 and mortality 13.4/100.000. Triple Negative Breast Cancers (TNBC) are regarded as one of the malignant phenotypes, principally accounting for 12-25% of invasive breast cancers. Material and Methods: Patients data was collected from hospital registry in our Institute Maharishi Markandeshwar Institute of Medical Sciences and Research (MMIMSR), Mullana, Ambala in Haryana from period 2015 to Dec 2018. All diagnosed cases of breast cancer were included in study. A total of 153 cases were registered. All patients had pathological diagnosis. Out of 153 patients 83 patients had IHC available.
Introduction
Worldwide, there are about 2.1 million newly diagnosed female breast cancer cases in 2018, which accounts for almost1 in 4 cancer cases among women. Carcinoma of breast is the most frequently diagnosed cancer in the most of the countries and is also the leading cause of cancer death (1) . According to Globocan 2018 breast cancer is the most common cancer in India with ASR incidence 24.7/100,000 and mortality 13.4/100.000. Although genetic and hereditary factors, including a personal or family history of www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i6.110 breast or ovarian cancer and inherited mutations (in BRCA1, BRCA2, and other breast cancer susceptibility genes), account for 5% to 10% of breast cancer cases, nonhereditary factors may be observed for international and interethnic differences in incidence. Migrants from low risk population to high risk population have increased incidence of carcinoma breast in successive population (2) . Countries with higher HDI have elevated incidence rates which is attributed to a higher prevalence of known risk factors and the elevated incidence rates are the consequence of a higher prevalence of known risk factors related to menstruation (early age at menarche, later age at menopause), reproduction (nulliparity, late age at first birth, and fewer children), exogenous hormone intake (oral contraceptive use and hormone replacement therapy), nutrition (alcohol intake), and anthropometry (greater weight, weight gain during adulthood, and body fat distribution); whereas breast feeding and physical activity are known protective factors (3) . Incidence rates of breast cancer have been rising in South America, Africa, and Asia. Rise in incidence may be because of economic and social development, including late age of childbearing, having fewer children, greater levels of obesity and physical inactivity, and increases in breast cancer screening and awareness. Epidemiology of breast cancer across different population based cancer registries (PBCRs) in India shows increasing trends for incidence and mortality mainly due to rapid urbanization, industrialization, population growth and ageing affecting all parts of India (4) . Triple negative breast cancer (TNBC) is a recently identified biological variant with aggressive tumor behavior and poor prognosis. Triple Negative Breast Cancers (TNBC) are regarded as one ofthe malignant phenotypes, principally accounting for 12-25% of invasive breast cancers. TNBCs lack expression of estrogen receptor (ER) and progesterone receptor (PR) and do not overexpress tyrosinekinase human epidermal growth factor receptor 2. The basal subset of TNBC is characterized by expression of basal type cytokeratin 5 and cytokeratin 6 and high expression of epidermal growth factor receptor, and frequently exhibits aggressive clinical behavior. TNBCs most frequently occur in women with germ line BRCA1 mutations and in premenopausal women of African descent (5, 6, 7) . TNBC accounts for approximately 12% to 17% of all invasive breast cancers in Western populations. TNBC occurs more frequently in younger women and is associated with higher histologic grade and more advanced disease. In North America, it is more frequently seen in women of African American ethnicity compared with other ethnic groups. Age-standardized 5-year breast cancer survival for Indian women diagnosed with breast cancer is 60% compared with 80% in Western countries. Whereas breast cancer incidence seems to be increasing in India, epidemiology of the disease is inadequately studied (8) . (9) . Whereas breast cancer incidence seems to be increasing in the country, epidemiology of thedisease is inadequately studied. Increasing urbanization and westernization associated with changing lifestyle and food habits has lead breast cancer to attain top position in all major urban registries. Among all the PBCR's top four places were occupiedby Delhi with AAR 41.0 (per 100,000), Chennai37.9, Bangalore 34.4 and Thiruvananthapuram District 33.7. Indian women having breast cancer are found a decade younger in comparison to western women suggesting that breast cancer occurs at a younger premenopausal age in India (10, 11, 12) . Studies suggest that the disease peaks at 40-50 years in Indian women JMSCR Vol||07||Issue||06||Page 642-647||June 2019 (13) . Our study also corroborates these findings where we observed that 60% patients were less than 50 years old. Trends for age distribution among different registries in India showed a peak relative proportion between 45 and 49 years in all registries except in north eastern registries where the peak is seen in even 10-year younger age group 35-39 (14) . Various studies have reported association of various risk factors with breast cancer in Indian women. Women have strong association of risk factors like breast-feeding, location (urban/rural) and increased BMI with breast cancer (P <0.05) (15) . Protective effects include increased breast feeding, physical activity and living in rural areas which decreases the risk for breast carcinoma as compared to urban counterparts. Other risk factors observed were increased waist-hip ratio, obesity, increasing age, low parity (three or more pregnancies getting associated with a 40-50% reduction in risk (P <0.01) (16, 17, 18) . Stage of disease at diagnosis is a critical determinant in breast cancer survival. Around 50% of breast cancer cases in India present at late stage (stage III and IV) (19) . Whereas in developed countries like the United States, only 12% of the breast cancer cases are diagnosed at an advanced stage (20) . In our study 42% of cases presented in late stages (III and IV) where as 34.3% in early stages. Age, axillary nodal status, tumour size, pathologic grade, and hormone receptor status are important prognostic and/or predictive factors (21) (22) (23) (24) . In this study 35% of patients were axillary lymph node positive, where as 56.7% of patients had grade III disease. Various studies from Asian subcontinent has shown ER, PR hormonal status positivity in range of 28% to 60% (25) , where as in our study ER and PR positive were 13.7% and 12.4% respectively. Triple negative breast cancer (TNBC) is an aggressive subtype that is defined by lack of expression of ER and PR as well as absence of overexpressed or amplified HER2. TNBC accounts for approximately 12% to 17% of all invasive breast cancers in Western populations (26) . In our study 43% percent of cases were TNBC. TNBC occurs more frequently in younger women and is associated with higher histologic grade and more advanced disease. In North America, it is more frequently seen in women of African American ethnicity compared with other ethnic groups (27, 28, 29) . Prevalence of TNBC in India ranged from 27% to 35% across studies, with a summary estimate of 31% (30) . This is comparable to the prevalence seen in African American women and is more than twice the rate seen in white women (31, 32, 33, 34) .
Methods

Conclusion
Breast cancer is the most common cancer in India. In our study it was observed that most of the patients were 40-60 years age. Majority of the patients had grade III tumor. Incidence of TNBC was found to be higher in our study. Larger data is required for conclusive results.
